BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34113784)

  • 1. Superior Frontal Gyrus
    Bezuch N; Bradburn S; Robinson AC; Pendleton N; Payton A; Murgatroyd C
    J Alzheimers Dis Rep; 2021 Apr; 5(1):275-282. PubMed ID: 34113784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.
    Shao Y; Shaw M; Todd K; Khrestian M; D'Aleo G; Barnard PJ; Zahratka J; Pillai J; Yu CE; Keene CD; Leverenz JB; Bekris LM
    J Hum Genet; 2018 Apr; 63(4):459-471. PubMed ID: 29371683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The APOE Gene is Differentially Methylated in Alzheimer's Disease.
    Foraker J; Millard SP; Leong L; Thomson Z; Chen S; Keene CD; Bekris LM; Yu CE
    J Alzheimers Dis; 2015; 48(3):745-55. PubMed ID: 26402071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    Mise A; Yoshino Y; Yamazaki K; Ozaki Y; Sao T; Yoshida T; Mori T; Mori Y; Ochi S; Iga JI; Ueno SI
    J Alzheimers Dis; 2017; 60(3):1107-1117. PubMed ID: 28984592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE genotype-specific methylation patterns are linked to Alzheimer disease pathology and estrogen response.
    Panitch R; Sahelijo N; Hu J; Nho K; Bennett DA; Lunetta KL; Au R; Stein TD; Farrer LA; Jun GR
    Transl Psychiatry; 2024 Feb; 14(1):129. PubMed ID: 38424036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.
    Bruno D; Nierenberg JJ; Ritchie JC; Lutz MW; Pomara N
    Psychoneuroendocrinology; 2012 Mar; 37(3):366-71. PubMed ID: 21803501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variants.
    Prokopenko I; Miyakawa G; Zheng B; Heikkinen J; Petrova Quayle D; Udeh-Momoh C; Claringbould A; Neumann J; Haytural H; Kaakinen MA; Loizidou E; Meissner E; Bertram L; ; Gveric DO; Gentleman SM; Attems J; Perneczky R; Arzberger T; Muglia P; Lill CM; Parkkinen L; Middleton LT
    Alzheimers Dement (N Y); 2019; 5():814-824. PubMed ID: 31788537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer's Disease.
    Valant V; Keenan BT; Anderson CD; Shulman JM; Devan WJ; Ayres AM; Schwab K; Goldstein JN; Viswanathan A; Greenberg SM; Bennett DA; De Jager PL; Rosand J; Biffi A;
    Transl Stroke Res; 2012 Jul; 3(Suppl 1):102-12. PubMed ID: 24323865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
    Lindqvist D; Prokopenko I; Londos E; Middleton L; Hansson O
    J Parkinsons Dis; 2016; 6(1):99-108. PubMed ID: 26756745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease.
    Lee EG; Tulloch J; Chen S; Leong L; Saxton AD; Kraemer B; Darvas M; Keene CD; Shutes-David A; Todd K; Millard S; Yu CE
    PLoS One; 2020; 15(1):e0227667. PubMed ID: 31978088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory Dysfunction in ApoE ɛ4/4 Homozygotes with Alzheimer's Disease.
    Oleson S; Murphy C
    J Alzheimers Dis; 2015; 46(3):791-803. PubMed ID: 25869786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease.
    Sabbagh MN; Malek-Ahmadi M; Dugger BN; Lee K; Sue LI; Serrano G; Walker DG; Davis K; Jacobson SA; Beach TG
    BMC Neurol; 2013 May; 13():44. PubMed ID: 23663404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
    Salami A; Adolfsson R; Andersson M; Blennow K; Lundquist A; Adolfsson AN; Schöll M; Zetterberg H; Nyberg L
    J Alzheimers Dis; 2022; 85(3):1309-1320. PubMed ID: 34924376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE.
    Bekris LM; Lutz F; Yu CE
    J Hum Genet; 2012 Jan; 57(1):18-25. PubMed ID: 22089642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
    Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
    J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.
    Hultman K; Strickland S; Norris EH
    J Cereb Blood Flow Metab; 2013 Aug; 33(8):1251-8. PubMed ID: 23652625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
    J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.